Cancer vaccines are showing remarkable promise, while new tariff proposals could reshape global trade.
Today's EX POST!™ Afternoon Edition examines two stories that could affect millions in very different ways.
Read more at @EXPostNewsMedia
Cancer vaccines are showing remarkable promise, while new tariff proposals could reshape global trade.
Today's EX POST!™ Afternoon Edition examines two stories that could affect millions in very different ways.
Read more at @EXPostNewsMedia
Breast cancer genomic test could spare millions from chemotherapy
The night before my Grandpa John was going to have surgery to remove his voicebox, he made a different choice. This is a story about one decision he made in the 70s, and why I Relay today...
Donate at
Http://main.acsevents.org/goto/jlizak
Cancer stem cells drive tumor formation, therapy resistance, and relapse.
Emerging research in biomarkers, metabolic inhibition, nanotechnology, and engineered immune therapies is redefining how treatment can target the root of disease.
These advances support more precise, durable, and personalized approaches across many cancer types.
Visit Banish Cancer Blog for more.
#CancerResearch #StemCellBiology #HealthEquity #BanishCancer #Oncology
Richard Scolyer, cancer researcher and former Australian of the year, dies aged 59
By Guardian staff
Scolyer, who did pioneering work on immunotherapy, was diagnosed with inoperable brain cancer in 2023
#Australianews #Cancerresearch #Cancer #Medicalresearch #Science #Health #Guardianstaff
Richard Scolyer, acclaimed melanoma researcher who tried experimental treatment on his own brain cancer – obituary
By Jennifer King
Pathologist and athlete who was Australian of the year in 2024 underwent a bold experimental treatment after devastating brain cancer diagnosis
#Cancerresearch #Medicalresearch #Health #Cancer #Australianews #Science #JenniferKing
Richard Scolyer, cancer researcher and former Australian of the year, dies aged 59
By Guardian staff
Scolyer, who did pioneering work on immunotherapy, was diagnosed with inoperable brain cancer in 2023
#Australianews #Cancerresearch #Cancer #Medicalresearch #Science #Health #Guardianstaff
Richard Scolyer, cancer researcher and former Australian of the year, dies aged 59
By Guardian staff
Scolyer, who did pioneering work on immunotherapy, was diagnosed with inoperable brain cancer in 2023
#Australianews #Cancerresearch #Cancer #Medicalresearch #Science #Health #Guardianstaff